{"entity":{"id":"nct07159204","kind":"trial","name":"Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer","aka":["PILOT-BTC"],"tldr":"A phase 2 trial of paclitaxel in gallbladder cancer and other biliary tract cancers, run by Peking Union Medical College Hospital, active and no longer recruiting.","summary":"Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer is a phase 2 interventional study registered as NCT07159204 by Peking Union Medical College Hospital, with a registry enrolment figure of 61 participants, started 2024-08-07 and due to reach its primary completion in 2026-08-12. Interventions recorded: Paclitaxel polymer micelle immunocombination. Conditions listed: Biliary Tract Cancer (BTC). Gallbladder cancer is named in the registry entry: \"* Patients with advanced biliary tract carcinoma diagnosed by imaging and histology as unresectable, recurrent, locally advanced, or metastatic disease, defined as stage IIIA or above according to the AJCC 8th edition st\". Sites: China. No results are recorded here; the registry entry is the source.","status":"active","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT07159204","url":"https://clinicaltrials.gov/study/NCT07159204"}],"tags":["ctgov-ingest","gallbladder-deep-dive"],"related":[],"cancers":["gallbladder","cholangiocarcinoma","intrahepatic-cholangiocarcinoma","extrahepatic-cholangiocarcinoma","biliary-tract-cancer"],"sections":[],"technologies":["cytotoxic-chemotherapy"],"targets":[],"drugs":["paclitaxel"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07159204","phase":"2","setting":"Polymeric Micellar Paclitaxel-Based Chemoimmunotherapy Plus Lenvatinib After First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer","sponsor":"Peking Union Medical College Hospital","enrolled":61,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07159204/","neighbours":{"cancer":[{"id":"biliary-tract-cancer","kind":"cancer","name":"Biliary tract cancer (all types)","route":"/cancers/biliary-tract-cancer/"},{"id":"cholangiocarcinoma","kind":"cancer","name":"Biliary tract cancer (cholangiocarcinoma)","route":"/cancers/cholangiocarcinoma/"},{"id":"extrahepatic-cholangiocarcinoma","kind":"cancer","name":"Extrahepatic cholangiocarcinoma (perihilar and distal)","route":"/cancers/extrahepatic-cholangiocarcinoma/"},{"id":"gallbladder","kind":"cancer","name":"Gallbladder cancer","route":"/cancers/gallbladder/"},{"id":"intrahepatic-cholangiocarcinoma","kind":"cancer","name":"Intrahepatic cholangiocarcinoma","route":"/cancers/intrahepatic-cholangiocarcinoma/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"}],"drug":[{"id":"paclitaxel","kind":"drug","name":"Paclitaxel / nab-paclitaxel","route":"/drugs/paclitaxel/"}],"term":[{"id":"gallbladder-cancer-in-biliary-trials","kind":"term","name":"Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)","route":"/terms/gallbladder-cancer-in-biliary-trials/"}]}}